Abstract

Like many neurodegenerative disorders, Parkinson's disease (PD) is clinically highly heterogeneous. A number of studies have proposed and defined subtypes of PD based on clinical features that tend to cluster together. These subtypes present an opportunity to refine studies of aetiology, course and treatment responsiveness in PD, as clinical variability must represent underlying biological or pathophysiological differences between individuals. In this paper, we review what subtypes have been identified in PD and the validation they have undergone. We then discuss what the subtypes could tell us about the disease and how they have been incorporated into studies of aetiology, progression and treatment. Finally, with the knowledge that they have been incorporated very little into PD clinical research, we make recommendations for how subtypes should be used and make some practical recommendations to address this lack of knowledge translation.

Keywords

Translation (biology)Parkinson's diseaseDiseaseMedicineBiologyGeneticsPathology

Affiliated Institutions

Related Publications

Parkinson disease

Parkinson disease (PD) is the most common neurodegenerative movement disorder. In Europe, prevalence and incidence rates for PD are estimated at approximately 108–257/100 000 an...

2019 European Journal of Neurology 1340 citations

Publication Info

Year
2012
Type
review
Volume
84
Issue
4
Pages
409-415
Citations
233
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

233
OpenAlex

Cite This

Connie Marras, Anthony E. Lang (2012). Parkinson's disease subtypes: lost in translation?. Journal of Neurology Neurosurgery & Psychiatry , 84 (4) , 409-415. https://doi.org/10.1136/jnnp-2012-303455

Identifiers

DOI
10.1136/jnnp-2012-303455